Glutathione Peroxidase 4 Antibody (Rabbit mAb) [P24F22]

Catalog No.: F6076

    Application: Reactivity:
    • Lane 1: 22Rv1, Lane 2: U-118 MG, Lane 3: U-937
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min

    使用情報

    Dilution
    1:1000
    1:1600 - 1:6400
    Application
    WB, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    22 kDa
    ポジティブコントロール Human ductal breast carcinoma; Human endometrioid adenocarcinoma; Human adenoid cystic carcinoma of salivary gland; Human papillary thyroid carcinoma; Human lung adenocarcinoma; Normal human colon; Human tonsil; Normal human kidney; Normal human epididymis; Normal human adrenal gland; Normal human stomach; Mouse testis; Rat testis; Human endometrioid adenocarcinoma; U-118 MG cells; Hep 3B2.1-7 cells; U-937 cells; 22Rv1 cells; 293T cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IHC
    Experimental Protocol:
     
    Deparaffinization/Rehydration
    1. Deparaffinize/hydrate sections:
    2. Incubate sections in three washes of xylene for 5 min each.
    3. Incubate sections in two washes of 100% ethanol for 10 min each.
    4. Incubate sections in two washes of 95% ethanol for 10 min each.
    5. Wash sections two times in dH2O for 5 min each.
    6.Antigen retrieval: For Citrate: Heat slides in a microwave submersed in 1X citrate unmasking solution until boiling is initiated; continue with 10 min at a sub-boiling temperature (95°-98°C). Cool slides on bench top for 30 min.
     
    Staining
    1. Wash sections in dH2O three times for 5 min each.
    2. Incubate sections in 3% hydrogen peroxide for 10 min.
    3. Wash sections in dH2O two times for 5 min each.
    4. Wash sections in wash buffer for 5 min.
    5. Block each section with 100–400 µl of blocking solution for 1 hr at room temperature.
    6. Remove blocking solution and add 100–400 µl primary antibody diluent in to each section. Incubate overnight at 4°C.
    7. Remove antibody solution and wash sections with wash buffer three times for 5 min each.
    8. Cover section with 1–3 drops HRPas needed. Incubate in a humidified chamber for 30 min at room temperature.
    9. Wash sections three times with wash buffer for 5 min each.
    10. Add DAB Chromogen Concentrate to DAB Diluent and mix well before use.
    11. Apply 100–400 µl DAB to each section and monitor closely. 1–10 min generally provides an acceptable staining intensity.
    12. Immerse slides in dH2O.
    13. If desired, counterstain sections with hematoxylin.
    14. Wash sections in dH2O two times for 5 min each.
    15. Dehydrate sections: Incubate sections in 95% ethanol two times for 10 sec each; Repeat in 100% ethanol, incubating sections two times for 10 sec each; Repeat in xylene, incubating sections two times for 10 sec each.
    16. Mount sections with coverslips and mounting medium.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Glutathione Peroxidase 4 Antibody (Rabbit mAb) [P24F22] detects endogenous levels of total Glutathione Peroxidase 4 protein.
    タンパク質の局在
    細胞質、ミトコンドリア
    Uniprot ID
    P36969
    Clone
    P24F22
    Synonym(s)
    epididymis secretory sperm binding protein; Glutathione peroxidase 4; GPx-4; GPX4; GSHPx-4; MCSP; PHGPx; selenoprotein GPX4; SMDS; snGPx; snPHGPx; sperm nucleus glutathione peroxidase
    Background
    GPX4 (glutathione peroxidase 4) is a selenocysteine‑containing glutathione peroxidase that occupies a unique position in redox biology as the only enzyme that directly reduces complex phospholipid and cholesterol hydroperoxides within biological membranes and lipoproteins, using reduced glutathione as an electron donor and thereby maintaining the integrity of polyunsaturated phospholipids that are otherwise highly susceptible to iron‑driven peroxidation. The protein is a monomeric oxidoreductase whose catalytic center contains a selenocysteine residue that cycles between selenol and selenenic/selenyl–glutathione intermediates during the reaction 2 GSH + phospholipid–OOH → GSSG + phospholipid–OH + H₂O, and this capacity to act directly on membrane‑embedded hydroperoxides differentiates GPX4 from other family members that primarily handle soluble peroxides. GPX4 activity is central to suppression of ferroptosis, a regulated necrotic death pathway driven by unchecked iron‑dependent lipid peroxidation: loss or inhibition of GPX4 function causes accumulation of phospholipid hydroperoxides beyond a toxic threshold, collapse of membrane structure, and execution of ferroptotic death, whereas preserved GPX4 activity is sufficient to interrupt lipid peroxidation chain reactions and maintain cell viability despite high oxidative load. This function places GPX4 at the heart of the Xc⁻/GSH/GPX4 axis, in which cystine import via system Xc⁻, glutathione synthesis, and GPX4 activity form a linear defense against ferroptosis that is transcriptionally supported by Nrf2 and other stress‑response factors; disruption at any step sensitizes cells to ferroptosis, while selenium availability and selenocysteine incorporation into GPX4 are rate‑limiting determinants of its expression and activity. Isoforms of GPX4 localize to cytosol, mitochondria, and nucleus/testis, extending its protective role to mitochondrial membranes and chromatin‑associated lipids and making it essential for embryonic development, spermatogenesis, and long‑term neuronal survival, where GPX4 maintains synaptic and myelin membrane integrity and limits neurodegenerative cascades triggered by lipid peroxidation. Dysregulated GPX4 expression or activity contributes to diverse pathologies: impaired GPX4 promotes ferroptosis in ischemia–reperfusion injury, neurodegeneration, and inflammatory tissue damage, while GPX4 overexpression or enforced dependency characterizes many therapy‑resistant and high‑mesenchymal‑state cancer cells, including drug‑tolerant persister subpopulations that rely on GPX4‑mediated detoxification of lipid peroxides for survival under chemotherapy or targeted therapy pressure.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください